AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
102 hedge funds and large institutions have $322M invested in Aerie Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 51 increasing their positions, 23 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
52% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 23
Holders
102
Holding in Top 10
3
Calls
$1.43M
Puts
$816K
Top Buyers
| 1 | +$22.2M | |
| 2 | +$8.81M | |
| 3 | +$4.86M | |
| 4 |
Goldman Sachs
New York
|
+$4.85M |
| 5 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
+$2.57M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$11.5M | |
| 3 | -$5.7M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$4.37M |
| 5 |
RCMC
Rubric Capital Management (Connecticut)
Stamford,
Connecticut
|
-$2.99M |